Infectious cell culture supernatant containing SARS-CoV-2, former VOC Gamma GR/501Y.V3 (P.1+P.1.*) first detected in Brazil/Japan, isolate hCoV-19/Italy/LAZ-INMI-216isl/2021, clade GR.
Infectious cell culture supernatant containing SARS-CoV-2 isolate hCoV-19/Italy/LAZ-INMI-115isl/2020, Δ69-70, D614G (S), clade G. This strain is preserved under Viral Storage Medium -80C.
We offer a 5 day training session to colleagues from endemic regions. Participants will visit the Viroscience clinical virology lab, where they will perform all required laboratory and analysis procedures for the quantification rabies virus and neutralizing antibodies.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.2/NV-22-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P4-GII.4/NV-22-007. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P7-GII.6/NV-22-008. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-009. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P17-GII.17/NV-22-010. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2022/GII.P16-GII.4/NV-22-099. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-004. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P5-GI.5/NV-23-006. Material 10-20% fecal material in virus culture medium.
